Theresa C. Kavanaugh

Dr. Kavanaugh has significant experience in developing patent strategies throughout the developmental life cycle of chemical and biologic therapeutics, including engineered foods, diagnostics and nutraceuticals. She has shepherded early stage patent development for discovery programs to post approval patent strategy for FDA-approved therapeutics - and then successfully through post grant and litigation challenge. Her strategic patent counseling, which has helped her clients achieve significant funding from acquisitions, public market offerings and private investments as well as extending market exclusivity for approved therapeutics, includes patentability, freedom to operate analyses, FDA Orange Book listing strategy and ANDA preparation for small molecules, biosimilar strategy for biologics, patent term extension strategy, and preparing for and conducting post grant patent review procedures, including Inter Partes Review (IPR) proceedings at the USPTO. She has extensive technical expertise with pharmaceutical and small molecule therapeutics; protein, antisense and other biologic therapies; diagnostic and drug discovery platform technologies, microbiome modulator technology; polymer chemistry; alternative food and nutraceutical technologies, drug delivery and extended release formulations; materials science; and chemical process technologies. Clients also benefit from her experience on IP matters as part of initial public offerings and venture investments.